Empiric outpatient therapy for community-acquired pneumonia is typically a macrolide such as azithromycin. Which of the following is an appropriate choice?

• A. Amoxicillin
• B. Macrolide (azithromycin)
• C. Tetracycline
• D. Cephalexin

Answer: (B)

Empiric outpatient CAP needs coverage of both typical bacteria and atypical pathogens because atypicals like Mycoplasma and Chlamydophila are common in this setting and lack conventional cell walls, making beta-lactams less reliable alone. Macrolides, such as azithromycin, inhibit protein synthesis and effectively cover these atypicals while also having good activity against common typical organisms like Streptococcus pneumoniae. This combination makes a macrolide a well-rounded first choice for otherwise healthy outpatients with CAP.

Amoxicillin concentrates on typical organisms and does not reliably cover atypicals, so it can miss important pathogens in outpatient CAP. Cephalexin is mainly active against gram-positive bacteria and lacks atypical coverage, limiting its usefulness for initial CAP treatment. Tetracycline can target atypicals but is less favored in certain patients (like children and pregnant individuals) and may have tolerability issues. Therefore, the macrolide stands out as the most appropriate empiric choice in this scenario.